The efficacy of a computerized assessment of medication adherence in active substance users

Journal of the International Association of Providers of AIDS Care

Volumn 12, Issue 4, 2013, Pages 232-235

  Newville, Howard ^a   Sorensen, James L ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

adherence; antiretroviral therapy; computerized assessment; substance use

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MEDICATION COMPLIANCE; PATIENT MONITORING; PREDICTIVE VALUE; PRIORITY JOURNAL; SELF REPORT; SUBSTANCE ABUSE; VIRUS LOAD; VISUAL ANALOG SCALE;

ADHERENCE; ANTIRETROVIRAL THERAPY; COMPUTERIZED ASSESSMENT; SUBSTANCE USE;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; ROC CURVE; SAN FRANCISCO; SELF REPORT; SUBSTANCE-RELATED DISORDERS; THERAPY, COMPUTER-ASSISTED; VIRAL LOAD;

EID: 84880435356     PISSN: 23259574     EISSN: 23259582     Source Type: Journal    
DOI: 10.1177/2325957413488206     Document Type: Article

References (25)

1. Gange SJ, Barrón Y, Greenblatt RM, et al. Effectiveness of highly active antiretroviral therapy among HIV-1 infected women. J Epidemiol Community Health. 2002 ; 56 (2). 153-159
2. Murphy EL, Collier AC, Kalish LA, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med. 2001 ; 135 (1). 17-26
3. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998 ; 338 (13). 853-860
4. Malta M, Strathdee SA, Magnanini MM, Bastos FI. Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction. 2008 ; 103 (8). 1242-1257
5. Kerr T, Hogg RS, Yip B, Tyndall MW, Montaner J, Wood E. Validity of self-reported adherence among injection drug users. J Int Assoc Physicians AIDS Care. 2008 ; 7 (4). 157-159
6. Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004 ; 5 (2). 74-79
7. Oyugi JH, Byakika-Tusiime J, Charlebois ED, et al. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr. 2004 ; 36 (5). 1100-1102
8. Garfield S, Clifford S, Eliasson L, Barber N, Willson A. Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Med Res Methodol. 2011 ; 11: 149
9. Metzger DS, Koblin B, Turner C, Navaline H, Valenti F, Holte S. Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. Am J Epidemiol. 2000 ; 152 (2). 99-106
10. Macalino GE, Celentano DD, Latkin C, Strathdee SA, Vlahov D. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ Prev. 2002 ; 14 (5). 367-378
11. Kalichman SC, Amaral CM, Swetzes C, et al. A simple single-item rating scale to measure medication adherence: further evidence for convergent validity. J Int Assoc Physicians AIDS Care. 2009 ; 8 (6). 367-374
12. Gill CJ, Sabin LL, Hamer DH, et al. Importance of dose timing to achieving undetectable viral loads. AIDS Behav. 2010 ; 14 (4). 785-793
13. Kagee A, Nel A. Assessing the association between self-report items for HIV pill adherence and biological measures. AIDS Care. 2012 ; 24 (11). 1448-1452
14. Gianotti N, Galli L, Bocchiola B, et al. Number of daily pills, dosing schedule, self-reported adherence and health status in 2010: a large cross-sectional study of HIV-infected patients on antiretroviral therapy. HIV Med. 2013 ; 14 (3). 153-60
15. Kerr SJ, Avihingsanon A, Putcharoen O, et al. Assessing adherence in Thai patients taking combination antiretroviral therapy. Int J STD AIDS. 2012 ; 23 (3). 160-165
16. Buscher A, Hartman C, Kallen MA, Giordano TP. Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naïve, HIV patients. HIV Clin Trials. 2011 ; 12 (5). 244-254
17. Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006 ; 43 (suppl 1). S79 - S87
18. Walsh JC, Dalton M, Gazzard BG. Adherence to combination antiretroviral therapy assessed by anonymous patient self-report. AIDS. 1998 ; 12 (17). 2361-2363
19. McLellan AT, Cacciola JS, Zanis D University of Pennsylvania/Philadelphia VA Medical Center: Center for the Studies of Addiction ; 1997 :
20. Grzybowski M, Younger JG. Statistical methodology: III. Receiver operating characteristic (ROC) curves. Acad Emerg Med. 1997 ; 4 (8). 818-826
21. Landis JR., Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977 ; 33 (1). 159-174
22. Bisson GP, Gross R, Strom JB, et al. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy. AIDS. 2006 ; 20 (12). 1613-1619
23. Bisson GP, Gross R, Bellamy S, et al. Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy. PLoS Med. 2008 ; 5 (5). e109
24. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor and outcomes in patients with HIV infection. Ann Intern Med. 2000 ; 133 (1). 21-30
25. Bangsberg DR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006 ; 43 (7). 939-941